Clinical Trial Update: Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating internal mammary lymph node irradiation for high-risk breast cancer after neoadjuvant chemotherapy, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING